Infection

ParkOhio Announces Extension of Credit Agreement

Retrieved on: 
Thursday, September 21, 2023

Park-Ohio Holdings Corp. (NASDAQ: PKOH) today announced that it has amended and restated its existing revolving credit facility.

Key Points: 
  • Park-Ohio Holdings Corp. (NASDAQ: PKOH) today announced that it has amended and restated its existing revolving credit facility.
  • ParkOhio is a diversified international company providing world-class customers with a supply chain management outsourcing service, capital equipment used on their production lines, and manufactured components used to assemble their products.
  • Headquartered in Cleveland, Ohio, ParkOhio operates more than 130 manufacturing sites and supply chain logistics facilities worldwide, through three reportable segments: Supply Technologies, Assembly Components and Engineered Products.
  • The following table reconciles net cash provided by operating activities to free cash flow:
    Forecast --Year Ending December 31, 2023

First Trust Mortgage Income Fund Increases its Monthly Common Share Distribution to $0.0675 Per Share for October

Retrieved on: 
Wednesday, September 20, 2023

First Trust Mortgage Income Fund (the "Fund") (NYSE: FMY) has increased its regularly scheduled monthly common share distribution to $0.0675 per share from $0.0625 per share.

Key Points: 
  • First Trust Mortgage Income Fund (the "Fund") (NYSE: FMY) has increased its regularly scheduled monthly common share distribution to $0.0675 per share from $0.0625 per share.
  • The Fund is a diversified, closed-end management investment company that seeks to provide a high level of current income.
  • First Trust Advisors L.P. ("FTA") is a federally registered investment advisor and serves as the Fund's investment advisor.
  • FTA and its affiliate First Trust Portfolios L.P. ("FTP"), a FINRA registered broker-dealer, are privately-held companies that provide a variety of investment services.

Global Chemiluminescence Immunoassay Industry Research Report 2023: Increasing Incidence of Diseases and Technological Advancements to Drive Market Expansion to 2028 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, September 20, 2023

The "Global Chemiluminescence Immunoassay Market by Product (Instrument, Consumable), Technology (Chemiluminescence Enzyme, Microparticle Chemiluminescence), Sample (Blood, Urine), Application (Infectious Disease, Oncology), End User - Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Chemiluminescence Immunoassay Market by Product (Instrument, Consumable), Technology (Chemiluminescence Enzyme, Microparticle Chemiluminescence), Sample (Blood, Urine), Application (Infectious Disease, Oncology), End User - Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.
  • The global chemiluminescence immunoassay market, valued at approximately USD 13.2 billion in 2023, is expected to experience significant growth, reaching USD 19.0 billion by 2028, with a notable CAGR of 7.5%.
  • This comprehensive report provides valuable insights for both established market leaders and newcomers, offering precise revenue estimations for the overall market and its subsegments.
  • Oncology testing segment is expected to grow at the highest rate within the chemiluminescence immunoassay market.

First Trust Intermediate Duration Preferred & Income Fund Declares its Monthly Common Share Distribution of $0.1075 Per Share for October

Retrieved on: 
Wednesday, September 20, 2023

First Trust Intermediate Duration Preferred & Income Fund (the "Fund") (NYSE: FPF) has declared the Fund’s regularly scheduled monthly common share distribution in the amount of $0.1075 per share payable on October 16, 2023, to shareholders of record as of October 3, 2023.

Key Points: 
  • First Trust Intermediate Duration Preferred & Income Fund (the "Fund") (NYSE: FPF) has declared the Fund’s regularly scheduled monthly common share distribution in the amount of $0.1075 per share payable on October 16, 2023, to shareholders of record as of October 3, 2023.
  • The Fund is a diversified, closed-end management investment company that seeks to provide a high level of current income.
  • The Fund seeks to achieve its investment objectives by investing in preferred and other income-producing securities.
  • First Trust Advisors L.P. ("FTA") is a federally registered investment advisor and serves as the Fund's investment advisor.

First Trust High Yield Opportunities 2027 Term Fund Declares its Monthly Common Share Distribution of $0.13 Per Share for October

Retrieved on: 
Wednesday, September 20, 2023

First Trust High Yield Opportunities 2027 Term Fund (the "Fund") (NYSE: FTHY) has declared the Fund’s regularly scheduled monthly common share distribution in the amount of $0.13 per share payable on October 25, 2023, to shareholders of record as of October 3, 2023.

Key Points: 
  • First Trust High Yield Opportunities 2027 Term Fund (the "Fund") (NYSE: FTHY) has declared the Fund’s regularly scheduled monthly common share distribution in the amount of $0.13 per share payable on October 25, 2023, to shareholders of record as of October 3, 2023.
  • The Fund has a practice of seeking to maintain a relatively stable, attractive monthly distribution which may be changed periodically.
  • High yield debt securities include U.S. and non-U.S. corporate debt obligations and senior, secured floating rate loans ("Senior Loans").
  • The Fund is not a "target term" Fund and its primary objective is to provide high current income.

First Trust Energy Infrastructure Fund Declares its Monthly Common Share Distribution of $0.10 Per Share for October

Retrieved on: 
Wednesday, September 20, 2023

First Trust Energy Infrastructure Fund (the "Fund") (NYSE: FIF) has declared the Fund’s regularly scheduled monthly common share distribution in the amount of $0.10 per share payable on October 16, 2023, to shareholders of record as of October 3, 2023.

Key Points: 
  • First Trust Energy Infrastructure Fund (the "Fund") (NYSE: FIF) has declared the Fund’s regularly scheduled monthly common share distribution in the amount of $0.10 per share payable on October 16, 2023, to shareholders of record as of October 3, 2023.
  • Under the Plan, the Fund intends to continue to pay a recurring monthly distribution that reflects the distributable cash flow of the Fund.
  • The distribution may consist of net investment income earned by the Fund, net short-term and long-term capital gains and/or tax-deferred return of capital.
  • The Fund seeks to achieve its investment objectives by investing primarily in securities of companies engaged in the energy infrastructure sector.

First Trust High Income Long/Short Fund Declares its Monthly Common Share Distribution of $0.105 Per Share for October

Retrieved on: 
Wednesday, September 20, 2023

First Trust High Income Long/Short Fund (the "Fund") (NYSE: FSD) has declared the Fund’s regularly scheduled monthly common share distribution in the amount of $0.105 per share payable on October 16, 2023, to shareholders of record as of October 3, 2023.

Key Points: 
  • First Trust High Income Long/Short Fund (the "Fund") (NYSE: FSD) has declared the Fund’s regularly scheduled monthly common share distribution in the amount of $0.105 per share payable on October 16, 2023, to shareholders of record as of October 3, 2023.
  • First Trust Advisors L.P. ("FTA") is a federally registered investment advisor and serves as the Fund's investment advisor.
  • FTA and its affiliate First Trust Portfolios L.P. ("FTP"), a FINRA registered broker-dealer, are privately-held companies that provide a variety of investment services.
  • FTP is also a distributor of mutual fund shares and exchange-traded fund creation units.

Kezar Life Sciences and Everest Medicines Enter into an Agreement to Develop and Commercialize Zetomipzomib for Lupus Nephritis and other Potential Indications in Greater China, South Korea and Southeast Asia

Retrieved on: 
Wednesday, September 20, 2023

Everest Medicines will have exclusive rights to develop and commercialize zetomipzomib in Greater China, South Korea, Singapore, Malaysia, Thailand, Indonesia, Vietnam and the Philippines.

Key Points: 
  • Everest Medicines will have exclusive rights to develop and commercialize zetomipzomib in Greater China, South Korea, Singapore, Malaysia, Thailand, Indonesia, Vietnam and the Philippines.
  • Everest Medicines will join Kezar on PALIZADE, a global, placebo-controlled Phase 2b clinical trial evaluating zetomipzomib in patients with active lupus nephritis (LN), in Greater China, South Korea and Southeast Asia.
  • In addition to LN, Kezar and Everest Medicines have the opportunity to collaborate on future clinical trials and indications for the continued development of zetomipzomib.
  • “This partnership with Everest Medicines is an important milestone in the development of zetomipzomib,” said John Fowler, co-founder and CEO of Kezar.

First Trust Dynamic Europe Equity Income Fund Declares its Monthly Common Share Distribution of $0.07 Per Share for October

Retrieved on: 
Wednesday, September 20, 2023

First Trust Dynamic Europe Equity Income Fund (the "Fund") (NYSE: FDEU) has declared the Fund’s regularly scheduled monthly common share distribution in the amount of $0.07 per share payable on October 16, 2023, to shareholders of record as of October 3, 2023.

Key Points: 
  • First Trust Dynamic Europe Equity Income Fund (the "Fund") (NYSE: FDEU) has declared the Fund’s regularly scheduled monthly common share distribution in the amount of $0.07 per share payable on October 16, 2023, to shareholders of record as of October 3, 2023.
  • Under the Plan, the Fund intends to continue to pay a monthly distribution in the amount of $0.07 per share.
  • This distribution may consist of net investment income earned by the Fund, net short-term and long-term capital gains and/or tax deferred return of capital.
  • The Fund is a diversified, closed-end management investment company that seeks to provide a high level of current income.

First Trust/abrdn Global Opportunity Income Fund Declares its Monthly Common Share Distribution of $0.06 Per Share for October

Retrieved on: 
Wednesday, September 20, 2023

First Trust/abrdn Global Opportunity Income Fund (the "Fund") (NYSE: FAM) has declared the Fund’s regularly scheduled monthly common share distribution in the amount of $0.06 per share payable on October 16, 2023, to shareholders of record as of October 3, 2023.

Key Points: 
  • First Trust/abrdn Global Opportunity Income Fund (the "Fund") (NYSE: FAM) has declared the Fund’s regularly scheduled monthly common share distribution in the amount of $0.06 per share payable on October 16, 2023, to shareholders of record as of October 3, 2023.
  • The Fund is a diversified, closed-end management investment company that seeks to provide a high level of current income.
  • FTP is also a distributor of mutual fund shares and exchange-traded fund creation units.
  • Market risk is the risk that a particular security, or shares of a fund in general may fall in value.